Form 4: Director Jeri Williams Executes Axon Stock Transactions

Director Jeri Williams reported the acquisition of restricted stock units and the subsequent sale of common stock in Axon Enterprise, Inc.

Summary

• Director Jeri Williams acquired 611 restricted stock units on May 29, 2026, which vest on the earlier of the one-year anniversary or the 2027 Annual Meeting.
• The director sold 406 shares at a weighted average price of $477.43 on June 1, 2026.
• An additional 223 shares were sold on June 1, 2026, at a price of $455.45.
• Following these transactions, the director holds 1,141 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were executed under a pre-established 10b5-1 plan, which is a routine administrative action.

Positives

• The director maintains a direct equity stake of 1,141 shares in the company, aligning interests with shareholders.

Negatives

• The director reduced their total direct beneficial ownership through the sale of 629 shares.

Risks

• Future share price volatility may impact the value of remaining holdings.
• Reliance on Rule 10b5-1 trading plans for divestment.

Future Outlook

The restricted stock units granted are scheduled to vest in full on the earlier of the one-year anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders.

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares and prices at which the transaction was effected upon request.

Industry Context

StockSavvy.ai notes that director divestments via pre-planned 10b5-1 programs are standard corporate governance practices and typically do not signal a lack of confidence in company performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a standard industry practice for executives and directors to manage equity holdings while avoiding potential insider trading concerns.

Stakeholder Impact

• Minimal impact on shareholders as the transactions were conducted under a pre-planned trading arrangement.

Next Steps

• Vesting of restricted stock units on or before the 2027 Annual Meeting of Shareholders.

Key Dates

Keywords

Axon Enterprise, AXON, Insider Trading, Form 4, Jeri Williams, Director Transactions